Search

Your search keyword '"Erik E. Berntorp"' showing total 5 results
Start Over Author "Erik E. Berntorp" Language swedish
5 results on '"Erik E. Berntorp"'

1. [Tranexamic acid--an old drug in a new costume. Multinational studies and new texts provide a boost for the antifibrinolytic agent].

Author

Tengborn L and Berntorp E

Subjects
Drug Utilization, Humans, Randomized Controlled Trials as Topic, Antifibrinolytic Agents administration & dosage, Antifibrinolytic Agents adverse effects, Antifibrinolytic Agents pharmacology, Antifibrinolytic Agents therapeutic use, Tranexamic Acid administration & dosage, Tranexamic Acid adverse effects, Tranexamic Acid pharmacology, Tranexamic Acid therapeutic use
Published
2013

2. [Rare hereditary types of hemophilia. Bleeding symptoms, family history and laboratory analyses indicates diagnosis].

Author

Knobe K, Astermark J, Berntorp E, Hillarp A, Strandberg K, and Svensson PJ

Subjects
Adult, Aged, Blood Coagulation Factors analysis, Blood Coagulation Factors genetics, Blood Coagulation Factors physiology, Diagnosis, Differential, Female, Humans, Infant, Newborn, Male, Blood Coagulation Disorders, Inherited diagnosis, Blood Coagulation Disorders, Inherited genetics, Blood Coagulation Disorders, Inherited therapy, Hemophilia A diagnosis, Hemophilia A genetics, Hemophilia A therapy, Hemorrhagic Disorders diagnosis, Hemorrhagic Disorders genetics, Hemorrhagic Disorders therapy
Published
2011

3. [Von Willebrand disease--from biochemistry to clinical practice].

Author

Sveinsdottir SV, Hillarp A, Astermark J, Svensson PJ, and Berntorp E

Subjects
Aged, Antifibrinolytic Agents therapeutic use, Deamino Arginine Vasopressin therapeutic use, Female, Hemostatics therapeutic use, Humans, Male, Middle Aged, Tranexamic Acid therapeutic use, von Willebrand Disease, Type 1 diagnosis, von Willebrand Disease, Type 1 drug therapy, von Willebrand Disease, Type 1 genetics, von Willebrand Disease, Type 2 diagnosis, von Willebrand Disease, Type 2 drug therapy, von Willebrand Disease, Type 2 genetics, von Willebrand Disease, Type 3 diagnosis, von Willebrand Disease, Type 3 drug therapy, von Willebrand Disease, Type 3 genetics, von Willebrand Diseases diagnosis, von Willebrand Diseases drug therapy, von Willebrand Diseases genetics
Published
2010

4. [Prothrombin complex concentrate good in warfarin induced hemorrhage. Quick reversal--plasma should be avoided].

Author

Själander A, Berntorp E, and Svensson PJ

Subjects
Aged, Aged, 80 and over, Anticoagulants administration & dosage, Fibrinolytic Agents administration & dosage, Hematoma, Subdural surgery, Hemorrhage chemically induced, Humans, International Normalized Ratio, Postoperative Hemorrhage drug therapy, Postoperative Hemorrhage prevention & control, Punctures, Risk Factors, Vitamin K administration & dosage, Warfarin administration & dosage, Anticoagulants adverse effects, Blood Coagulation Factors therapeutic use, Hemorrhage drug therapy, Warfarin adverse effects
Published
2009

5. [Bleeding time determination is out of date. A non-reliable method which should not be used in routine care].

Author

Radulovic V, Svensson P, Hillarp A, and Berntorp E

Subjects
Age Factors, Blood Coagulation Disorders blood, Blood Coagulation Disorders genetics, Blood Loss, Surgical prevention & control, Female, Humans, Male, Predictive Value of Tests, Preoperative Care methods, Sensitivity and Specificity, Sex Factors, Bleeding Time, Blood Coagulation Disorders diagnosis, Blood Coagulation Tests
Published
2008

Catalog

Books, media, physical & digital resources
See catalog results